$QUCY

Quantum Cyber N.V.

Quantum Cyber, headquartered in Mainz, Germany, develops diagnostic tests for cancer and is expanding its business focus into post-quantum cybersecurity. Its current product development focuses on pancreatic cancer detection: a blood test using licensed mRNA biomarkers and an AI-developed algorithm, and PancAlert, a stool-based screening test. The company has an exclusive license to develop the blood test, with an option to acquire the biomarkers and algorithm. It has received government grants to cover a percentage of PancAlert project costs. Quantum Cyber historically marketed ColoAlert, a stool-based colorectal cancer screening test, to laboratories across Europe, and developed a next-generation colorectal cancer test. It sold ColoAlert’s intellectual property in March 2026 and is marketing the next-generation candidates’ intellectual property for sale. The company has ceased developing those colorectal products and is focusing on pancreatic cancer screening.

0
1
0

No SEC Form 4 filings for $QUCY in the last 30 days.

See all $QUCY insider activity →
Med

Quantum Cyber N.V. (QUCY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of William Caragol, Chief Financial Officer On November 20, 2026, William Caragol notified Quantum Cyber N.V.,

Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter…

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter 2026 Form 10-Q Highlights: ● Four customers each accounting for 10% or more of quarterly revenue, with no single

Quantum Cyber earnings matched, revenue topped estimates

Quantum Cyber (QUCY) reported Q3 EPS of -$0.08, matching estimates, with revenue of $970K, exceeding the $950K consensus. The stock is down 61.74% over 3 months and 61.34% over 12 months. InvestingPro rates its financial health as 'weak performance'.

QUCY sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning QUCY (Quantum Cyber N.V.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent QUCY coverage spans corporate actions, earnings and financial news.

What's driving QUCY

AlphAI scores every news story that mentions QUCY with an AI model for sentiment and relevance, and aggregates insider trades from Quantum Cyber N.V.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $QUCY

Score
$QUCYMedExec change· appointed

Quantum Cyber N.V. (QUCY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of William Caragol, Chief Financial Officer On November 20, 2026, William Caragol notified Quantum Cyber N.V.,

$QUCYMedEarnings

Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter…

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter 2026 Form 10-Q Highlights: ● Four customers each accounting for 10% or more of quarterly revenue, with no single

Quantum Cyber Expands Quantum Photonics License With New Royalty Terms

Quantum Cyber amended its IP license with Project LightShift, expanding coverage to quantum photonic array tech and new applications. The deal allows sublicensing without consent, adjusts royalty terms, and introduces a payment to LightShift after Quantum Drones recovers costs. According to the company, the amendment grants LightShift rights to certain improvements, subject to royalties.

$QUCYLowContract· customer

Quantum Cyber N.V. (QUCY): Entry into a Material Definitive Agreement

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on June 11, 2026, Quantum Cyber N.V. (the “Company”) entered into an Intellectual Property License Agreement (the “License Agreement”) with Project LightShift, Inc. (“LightShift”), pursuant to which Li

$QUCYLowExec change· appointed

Quantum Cyber N.V. (QUCY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Alberto C. Rosende Effective as of October 12, 2026, to fill the vacancy in the composition of the Board of

Quantum Cyber N.V. (QUCY) Appoints Maj. Gen. Rosende to Board

Quantum Cyber N.V. (QUCY) added Maj. Gen. (Ret.) Alberto C. Rosende to its board to oversee its Bridgeport, CT facility and supply chain for autonomous drones. The move supports the company's focus on domestic, vertically integrated manufacturing to meet U.S. demand, which could become a revenue catalyst if milestones are met.

$QUCYMedOffering· $100M · proposed

Quantum Cyber N.V. (QUCY): Entry into a Material Definitive Agreement

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 9, 2026, in connection with the launch of an “at the market” offering program, Quantum Cyber N.V. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Titan Partners Securities LLC, as sales a

Related tickers